Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: Panagiotis Kotsantis Clear advanced filters
  • Cancer cells proliferate at high rates and incur replication stress. Here, the authors show that this can be the consequence of oncogene-induced higher transcriptional activity, which, through increased RNA synthesis and R-loop accumulation, results in replication fork slowing and DNA damage.

    • Panagiotis Kotsantis
    • Lara Marques Silva
    • Eva Petermann
    ResearchOpen Access
    Nature Communications
    Volume: 7, P: 1-13
  • EXO1 performs multiple roles in DNA replication and DNA damage repair (DDR), but its role in DDR-deficient cancers remains unclear. Here, the authors find EXO1 loss as synthetic lethal with many DDR genes involved in various cancers, including genes from Fanconi Anaemia pathway, BRCA1-A complex, and spliceosome factor ZRSR2; such interactions represent potential clinical targets.

    • Marija Maric
    • Sandra Segura-Bayona
    • Simon J. Boulton
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-18
  • A phospho-switch is identified in the shelterin subunit TRF2 that regulates transient recruitment of the RTEL1 helicase to, and release from, telomeres, and provides a narrow window during which RTEL1 can unwind t-loops to facilitate telomere replication.

    • Grzegorz Sarek
    • Panagiotis Kotsantis
    • Simon J. Boulton
    Research
    Nature
    Volume: 575, P: 523-527
  • The tumour suppressor ARF regulates p53 levels; however, in contrast to p53, ARF has not been implicated in the response to DNA damage. In this study, Carlos et al.show that single-stranded DNA formed in BRCA2-null cells triggers a DNA damage response leading to the activation of ARF and senescence.

    • Ana Rita Carlos
    • Jose Miguel Escandell
    • Madalena Tarsounas
    Research
    Nature Communications
    Volume: 4, P: 1-14